Introduction
Endothelial dysfunction, activation and apoptosis are considered key features of sepsis. Microvesicles (MV) can be released by cells either constitutively, upon stimulation or apoptosis. Since endothelial derived microvesicles (EMV) were found to be elevated in diseases associated with endothelial activation and damage [1] they seem to be a promising diagnostic tool to assess the state of the endothelium.
Objectives
This study was aimed at testing the hypothesis that patients in early phase of septic shock have high levels of EMV circulating in blood.
Methods
Platelet free plasma was prepared from 18 healthy volunteers as well as 30 patients with septic shock treated in a medical intensive care unit and analyzed by high-sensitivity flow cytometry which has a high sensitivity for small and previously undetectable MV. Results were controlled for potential artifacts and absolute counts of different MV subtypes were compared between groups by using the MannWhitney-U test. Patients with an International Society of Thrombosis and Haemostasis (ISTH) -disseminated intravascular coagulation (DIC) score of at least five were classified as having an overt DIC. Results are presented as median and interquartile range.
Results
Absolute counts of CD144+, CD62E+ and CD106+ MV, specific for endothelial-derived MV, were low in patients with septic shock as well as in healthy volunteers. Patients with septic shock had higher levels of apparently predominantly leukocyte-derived CD31+/CD41-MV (58.48 (74.78) 
Conclusions
EMV considered as a manifestation of endothelial dysfunction in sepsis are not elevated in the majority of patients. Patients with septic shock who die within 48 hours exhibit features of excessive leukocyte-and platelet-activation.
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